Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acromegaly: historical perspectives and current therapy.

J A Jane1, K Thapar, E R Laws

  • 1Department of Neurosurgery, University of Virginia, Charlottesville, USA.

Journal of Neuro-Oncology
|January 5, 2002
PubMed
Summary

Neurosurgeons have long treated acromegaly, a condition of excess growth hormone. While medical therapies have advanced, surgery remains the most effective treatment for improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances and controversies in the classification and grading of pituitary tumors.

Journal of endocrinological investigation·2018
Same author

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.

Endocrine-related cancer·2017
Same author

Clinics in neurology and neurosurgery of sport: mass lesions. Benign brain tumours.

British journal of sports medicine·2009
Same author

Clinics in neurology and neurosurgery--extradural and subdural haematoma.

British journal of sports medicine·2008
Same author

Skull base chordomas: overview of disease, management options, and outcome.

Neurosurgical focus·2006
Same author

Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.

Clinical neuropathology·2005

Area of Science:

  • Endocrinology
  • Neurosurgery
  • Medical History

Background:

  • Acromegaly, a disorder caused by excess growth hormone (GH), was first described in the late 19th century.
  • Early treatments involved transcranial neurosurgical procedures.
  • The transsphenoidal surgical approach was later adopted and refined.

Observation:

  • Medical therapies for acromegaly emerged in the 1970s, with ongoing pharmacological advancements.
  • Excess GH is linked to substantial morbidity and mortality.
  • Biochemical remission of acromegaly is associated with improved patient outcomes.

Findings:

  • Surgery remains the primary treatment modality for acromegaly.
  • Transsphenoidal surgery offers optimal results for managing excess GH.
  • Medical and radiation therapies serve as valuable adjuncts to surgical intervention.

Implications:

  • Effective management of acromegaly through surgery can significantly reduce associated health risks.
  • Advances in neurosurgery and endocrinology continue to improve acromegaly treatment paradigms.
  • Achieving biochemical remission is crucial for enhancing the long-term prognosis of acromegaly patients.

Related Experiment Videos